We have recently shown that adhesion to E-selectin can directly promote significant resistance to cytotoxic chemotherapy in vitro and in vivo in mouse models of AML driven by the MLL-AF9 oncogene (Barbier et al., 2020). The gene discussed is MLLT3; the disease is acute myeloid leukemia.